CEBPB mRNA was higher in MetS than in non-MetS patients (p = 0.029, Figure 4A), and also a trend to higher values was observed in hyperglycemic compared with normoglycemic patients (p = 0.068) (Figure 4B). This evidence concerns the gene CEBPB and metabolic syndrome.